Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
28 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ausperbio-raises-50-million-in-series-b-to-advance-functional-cure-for-chronic-hepatitis-b-302467345.html
07 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ausperbio-presents-interim-phase-iib-ahb-137-clinical-data-in-a-late-breaking-abstract-at-easl-congress-2025-302449069.html
11 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ausperbio-reaches-key-milestone-with-dosing-completion-and-study-unblinding-in-ongoing-ahb-137-phase-iib-trial-302373308.html
11 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ausperbio-receives-breakthrough-therapy-designation-for-ahb-137-in-chronic-hepatitis-b-treatment-302194241.html
10 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ausperbio-receives-breakthrough-therapy-designation-for-ahb-137-in-chronic-hepatitis-b-treatment-302194241.html#:~:text=AHB%2D137%20gains%20Breakthrough%20Therapy,for%20chronic%20hepatitis%20B%20patients.
14 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ausperbio-announces-major-progress-in-ahb-137-clinical-development-302062101.html
ABOUT THIS PAGE